Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Veronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056/NEJMoa012782
Krag, 1998, The sentinel node in breast cancer—a multicenter validation study, N Engl J Med, 339, 941, 10.1056/NEJM199810013391401
Straver, 2010, Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial, Ann Surg Oncol, 17, 1854, 10.1245/s10434-010-0945-z
Veronesi, 2010, Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study, Ann Surg, 251, 595, 10.1097/SLA.0b013e3181c0e92a
Lyman, 2005, American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer, J Clin Oncol, 23, 7703, 10.1200/JCO.2005.08.001
Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001/jama.2011.90
Veronesi, 2009, Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases, Eur J Cancer, 45, 1381, 10.1016/j.ejca.2008.11.041
Naik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures, Ann Surg, 240, 462, 10.1097/01.sla.0000137130.23530.19
Smidt, 2005, Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance, Ann Surg Oncol, 12, 29, 10.1007/s10434-004-1166-0
Siponen, 2012, Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer, World J Surg, 36, 295, 10.1007/s00268-011-1399-6
Van Zee, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245/ASO.2003.03.015
Mansel, 2004, European studies on breast lymphatic mapping, Semin Oncol, 31, 304, 10.1053/j.seminoncol.2004.03.003
Olson, 2008, Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011, J Clin Oncol, 26, 3530, 10.1200/JCO.2007.15.5630
Lucci, 2007, Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011, J Clin Oncol, 25, 3657, 10.1200/JCO.2006.07.4062
Viale, 2001, Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma, Cancer, 92, 1378, 10.1002/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y
2002, 157
2010, 143
1988, Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group, N Engl J Med, 319, 1681, 10.1056/NEJM198812293192601
Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951
Veronesi, 2005, Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases, Ann Surg, 242, 101, 10.1097/01.sla.0000167927.82353.bc
Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial, Ann Surg, 252, 426, 10.1097/SLA.0b013e3181f08f32
Wasif, 2010, Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer, Arch Surg, 145, 161, 10.1001/archsurg.2009.269
Straver, 2010, Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer, J Clin Oncol, 28, 731, 10.1200/JCO.2008.21.7554
The EORTC. 10981-22023 AMAROS trial website: http://research.nki.nl/amaros/.
Colleoni, 2005, Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement, J Clin Oncol, 23, 1379, 10.1200/JCO.2005.07.094
Goldhirsch, 1998, Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer, J Natl Cancer Inst, 90, 1601, 10.1093/jnci/90.21.1601
Goldhirsch, 2009, Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009, Ann Oncol, 20, 1319, 10.1093/annonc/mdp322
Goldhirsch, 2003, Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer, J Clin Oncol, 21, 3357, 10.1200/JCO.2003.04.576